logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Capital Area Research LLC

+17179638389
Source: Site record.
http://care-research.com

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Capital Area Research (CARE) is an independent clinical research facility in Central Pennsylvania with more than 25 years of experience conducting clinical trials. The site supports Phase I–IV clinical research across therapeutic areas including cardiovascular disease, diabetes, infectious diseases, and other medical conditions. CARE provides comprehensive research capabilities, including patient recruitment and retention, clinical assessments, laboratory services, study coordination, and regulatory support. The site emphasizes participant safety, high-quality data, and efficient trial execution, making it a potential partner for sponsors and CROs seeking an experienced community-based research site.

Business Status

Source: Google. OPEN

Business Category

Source: Google. Research institute

Business Subcategory

Source: Google. Research institute
Source: Trial-derived.
6Total Trials
Source: Trial-derived.
1Recruiting Trials
Source: Trial-derived.
2Active Trials
Source: Trial-derived.
4Completed Trials
Source: Trial-derived.
13Unique Conditions
Source: Trial-derived.
8Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Artery Disease, Peripheral (1)Source: Trial-derived. Atherosclerosis (1)Source: Trial-derived. Coronary Artery Disease (1)Source: Trial-derived. Diabetes Mellitus, Type 2 (1)Source: Trial-derived. Femoropopliteal Artery Occlusion (1)Source: Trial-derived. Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention (1)Source: Trial-derived. Metabolic Syndrome (1)Source: Trial-derived. Peripheral Arterial Disease (1)

Sponsors

Source: Trial-derived. Beijing Inno Medicine Co., Ltd. (1)Source: Trial-derived. Cleerly, Inc. (1)Source: Trial-derived. CPC Clinical Research (1)Source: Trial-derived. Daiichi Sankyo (1)Source: Trial-derived. Eli Lilly and Company (1)Source: Trial-derived. Janssen Research & Development, LLC (1)Source: Trial-derived. SurModics, Inc. (1)Source: Trial-derived. The TIMI Study Group (1)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical microbiology culture
Source: AI-inferred. Timed pharmacokinetic sampling and processing

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Self-monitored blood glucose testing